R&D News | pharmaphorum

News

Hand in glove holding Petri plate with bacteria Steptococcus Phaemolifticus G, Streptococcus Agalactiae, Streptococcus Phaemolifticus

Minervax raises €47.4m in Series B funding round for GBS sho...

Denmark’s MinervaX has raised €47.4 million (around $56 million) in a Series B funding round to take its novel group B streptococcus (GBS) vaccine into mid-stage clinical trials.

News

Novartis/Incyte draw blank with Jakafi in COVID-19

Novartis/Incyte’s Jakafi (ruxolitinib) looks unlikely to be added to the list of therapies that can be used against COVID-19, after it failed to cut complications or death in a phase 3 tria

News

"Tokyo, Japan - May 11, 2012: Pfizer building on May 11, 2012 in Tokyo. Pfizer is one of largest pharmaceutical companies worldwide with tremendous revenue $67.4 bn USD for 2011. It exists since 1849."

FDA advisers vote in favour of Pfizer/BioNTech COVID-19 shot

Advisers to the FDA have voted in favour of approving Pfizer and BioNTech’s COVID-19 vaccine, with a near-unanimous backing from an expert committee.

News

ERT to merge with clinical imaging firm Bioclinica

ERT, a clinical services firm with expertise in digital technology is to merge with clinical imaging firm Bioclinica.

News

Lilly surges on positive phase 3 readout from diabetes conte...

Eli Lilly’s decision to throw large amounts of research dollars at its next-generation diabetes drug tirzepatide could be vindicated, according to its first phase 3 trial readout.<

News

Coronavirus vaccine may have allergy warning in US, says exp...

The US government’s coronavirus vaccine chief has said that Pfizer/BioNTech’s vaccine could carry a warning that it should be avoided by people who are prone to serious allergic reactions.<

Minervax raises €47.4m in Series B funding round for GBS sho...

Novartis/Incyte draw blank with Jakafi in COVID-19

FDA advisers vote in favour of Pfizer/BioNTech COVID-19 shot

ERT to merge with clinical imaging firm Bioclinica

Lilly surges on positive phase 3 readout from diabetes conte...

Coronavirus vaccine may have allergy warning in US, says exp...

Hengrui gets world-first okay for platelet drug hetrombopag

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks